Niger

in page functions
[French]
Total population (2016) 20,715,282
Birth cohort (2016) 1,018,244
Surviving Infants (surviving to 1 year per year, 2016) 963,947
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 57/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 96/1000
World Bank Index, IDA (2012) 3.39
Co-financing status (2016) Initial self-financing
No. of districts/territories (2015) 44

Gavi support for Niger

Type of support

Approvals

2001-2020 (US$)
(22 Jul 2016)

Commitments

2001-2020 (US$)
(22 Jul 2016)

Disbursements

2000-2016 (US$)
(22 Jul 2016)

% Disbursed

(22 Jul 2016)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Cash Support (CASHSUPP) $235,000 $260,000 $235,000 100%
Health system strengthening (HSS 1) $3,986,000 $3,986,000 $3,602,446 90%
Health system strengthening (HSS 2) $24,792,106 $40,025,092 $9,539,692 38%
HPV Demo (NVS) $599,142 $599,142 $610,200 102%
Immunisation services support (ISS) $8,055,365 $8,055,365 $8,055,365 100%
Injection safety support (INS) $943,757 $943,757 $943,757 100%
IPV (NVS) $1,664,720 $2,724,220 $1,402,617 84%
Penta (NVS) $43,493,651 $43,493,651 $42,601,223 98%
Pneumo (NVS) $36,924,911 $36,924,911 $43,740,928 118%
Rotavirus (NVS) $11,495,920 $11,495,920 $11,495,117 100%
Vaccine Introduction Grant (VIG) $2,825,500 $2,825,500 $2,825,500 100%
Yellow Fever (NVS) $4,414,792 $4,414,792 $4,886,058 111%
Total $139,430,864 $155,748,350 $129,937,903

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Niger DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 90%
M:F sex ratio at birth (2016) 1.05
Household survey: DTP3 coverage for male (2011) 67.50%
Household survey: DTP3 coverage for female (2011) 68.60%
Household survey: Last DTP3 survey (2011) 68%
% districts achieving > 80% DTP3 coverage (2015) 75%
% districts achieving < 50% DTP3 coverage (2015) 0%
MCV WHO/UNICEF estimates (2015) 73%

Breakdown of support

Non-vaccine support Vaccine support
19% 81%
$24,948,758 $104,736,139

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Niger

27 July 2016

First Sudanese child to receive Meningitis A vaccine as part of routine immunization.

Sudan: first to introduce life-saving meningitis A vaccine into routine immunization

Children in Sudan are set to become the first in the Meningitis belt to benefit from the introduction of Meningitis A vaccine into a routine immunization programme.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

10 November 2015

Gavi item

Scientists mark 'stunning success' of vaccine in virtually ridding Africa of meningitis A

New research forecasts a resurgence of meningitis A epidemics in 15 years should immunization efforts stall.

25 June 2015

Dr Seth Berkley, CEO of Gavi; Bill Gates Co-Chair of the Bill & Melinda Gates, Laurent Fabius, Minister of Foreign Affairs and International Development, Jean-Marc Gravellini, Executive Director in charge of Operations of the AFD.

Health in the Sahel region, together to improve immunisation programmes

The AFD, the Bill and Melinda Gates Foundation and Gavi signed an Initiative to increase coverage rates in six Sahel countries.

05 August 2014

Niger’s Minister of Health administers one of the first doses of vaccine to an infant.

Niger tackles its two biggest child killers with Gavi support

Life-saving pneumococcal and rotavirus vaccines are to be provided to all Niger’s children.

29 May 2013

WomenDeliverSeth.jpg

Vaccines against cervical cancer and rubella to benefit health of women and girls

Two new vaccines that help protect against cervical cancer, measles and rubella spearhead the GAVI Alliance’s commitment to improving the health of girls and women.

28 May 2013

Global Forum Cervical Cancer - Seth

Voices from the Global Forum on Cervical Cancer Prevention

Over 400 Government leaders, policymakers, healthcare professionals, NGOs and corporate leaders gathered for the first-ever Global Forum on Cervical Cancer Prevention on 27 May.

14 May 2013

Mariam

Kenya first country to protect girls against cervical cancer with GAVI support

Kenya becomes the first country to protect girls against cervical cancer with GAVI-supported human papillomavirus (HPV) vaccines.

08 May 2013

GAVI HPV Vaccine Infographic

04 February 2013

HPV

GAVI funds vaccines to protect girls against cervical cancer

More than 180,000 girls in eight developing countries are set to receive protection against the leading cause of cervical cancer thanks to human papillomavirus (HPV) vaccines funded by the GAVI Alliance.

10 January 2013

mopan

GAVI recognised for effectiveness and focus on results

In its first ever Multilateral Organisation Performance Assessment Network (MOPAN) review the GAVI Alliance has been commended for its effectiveness in increasing access to immunisation and for its focus on results.

03 December 2012

MenAfriVac

100 millionth person receives lifesaving meningitis vaccine

A revolutionary meningitis vaccine will reach the 100 millionth person this week in a region of Africa that has been plagued by deadly epidemics for more than a century. The milestone will take place in northern Nigeria, part of Africa’s “meningitis belt’, where the country is conducting its second seasonal immunisation campaign against the disease.

05 October 2012

Tanzania rotavirus rollout Sister Moshi

Useful information

Useful information for anyone attending the Partners' Forum in Tanzania: Climate, Passports & Visas, Health, Safety, General behaviour in public, Currency, Tipping, Electricity, Shopping

04 October 2012

MenAfriVac Path

GAVI partners help protect 50 million young people from seasonal meningitis in Africa

Efforts to eliminate meningitis in 26 at-risk countries will take a major step forward over the next three months as 50 million people receive crucial vaccinations in seven African countries.

25 May 2012

The Permanent Secretary in the Ministry of Health administers the first Rotateq to a child at Gataraga, Musanze

Rwanda introduces new vaccine against a leading childhood killer

Rotavirus vaccines will protect children from severe and deadly diarrhoea.

21 February 2012

Nigeria MenA

Q and A on Nigeria’s introduction of MenAfriVac

Interview with Muhammad Sani Adamu, Head of Accelerated Disease Control in Nigeria’s National Primary Health Care Development Agency, who played a key role in rolling out the new vaccine against meningitis A, MenAfriVac, to Nigeria’s northern states.

26 January 2012

Chad’s campaign against meningitis A

One of the first countries to introduce the new meningitis A vaccine (MenAfriVac), Chad ran an immunisation campaign with GAVI support in December 2011 to help eliminate the region’s devastating epidemics.

19 January 2012

Map showing Niger and Cameroon

GAVI works with Cameroon and Niger to recover misused funds

Following separate investigations into the misuse of GAVI funding in Cameroon and Niger, both Ministries of Health have cooperated fully and confirmed their commitment to take all necessary measures, including the reimbursement of misused funds.

27 September 2011

Accelerating Africa's access to rotavirus vaccine

Sudan's introduction of rotavirus vaccine earlier this year signalled the start of a wave of African countries ready to counter the world's leading cause of diarrhoeal deaths with GAVI support. In September, the Alliance approved funding for 12 more African countries to introduce the rotavirus vaccine.

17 July 2011

Sudan statement image Ethiopia

Milestone in preventing child deaths from diarrhoea in Africa

GAVI Alliance supports African introduction of rotavirus vaccines against the leading cause of severe infant diarrhoea.

10 June 2011

Rotavirus vaccinations in Ghana

Developing countries make record demand for life-saving vaccines

A record 50 GAVI eligible countries have applied for vaccine funding from the GAVI Alliance during the organisation’s latest application round, reported GAVI officials today.

11 May 2011

Burkina Faso Men A

GAVI commits US$ 100 million to fight meningitis A

The GAVI Alliance has committed US$ 100 million to help tackle meningitis A in Cameroon, Chad, and Nigeria, part of a strategy to save tens of thousands of lives in Africa with a new life-saving vaccine, MenAfriVac.

30 March 2011

GAVI Alliance steps up transparency on oversight of its cash programmes

To further increase transparency of the oversight of its cash-based support, the GAVI Alliance announced today that it will make public when it suspends a cash programme to investigate possible misuse of funds.

06 December 2010

Burkina Faso Men A launch 3

New meningitis A vaccine introduced in Burkina Faso

GAVI supports mass vaccination campaign in “meningitis belt”.

06 December 2010

Meningitis vaccine introduced in Africa's meningitis belt

For years and years, meningitis epidemics in the 25 countries of Africa's meningitis belt have caused death, disability and fear.

09 April 2009

GAVI partners mobilise to counter meningitis outbreaks

In an effort to save lives and contain the spread of meningitis, the GAVI Alliance has fast tracked a US$ 55 million contribution to establish a stockpile of meningococcal vaccines and pay for reactive campaigns in the highly endemic African “meningitis belt” countries.

close icon

modal window here